GGrantIndex
Sort

64,565 grants matching drug discovery

Functional genomics and DEC-Tec to identify germ cell-specific contraceptives

$1,234,662
Martin M Matzuk · Baylor College Of Medicine · P01 · FY2020 · HD

Functional genomics and DEC-Tec to identify germ cell-specific contraceptives

$1,234,662
Martin M Matzuk · Baylor College Of Medicine · P01 · FY2018 · HD

Discovery of Novel Drugs for Alzheimer's Disease

$1,234,178
James W. Simpkins · University Of North Texas Hlth Sci Ctr · P01 · FY2006 · AG

Transcription and Therapy for HD: from Molecules to Man

$1,233,746
Steven M Hersch · Massachusetts General Hospital · P01 · FY2006 · NS

DCTD Natural Products Extraction

$1,233,322
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA

Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder

$1,233,319
Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2021 · AA

SPORE In Prostate Cancer

$1,233,307
William George Nelson · Johns Hopkins University · P50 · FY2013 · CA

Interventional approaches for restoring vision

$1,233,046
Anand Swaroop · National Eye Institute · ZIA · FY2010 · EY

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,232,770
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

A Clinical Decision Support Tool for Electronic Health Records

$1,232,604
Stephen F Butler · Inflexxion, Inc. · R44 · FY2014 · DA

Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults

$1,232,581
Veronique Vanderhorst · Beth Israel Deaconess Medical Center · R01 · FY2022 · AG

Systems Biology of Tumor Progression and Drug Resistance

$1,232,072
Andrea Califano · Columbia University Health Sciences · U01 · FY2015 · CA

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center

$1,231,641
Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2022 · CA

Cocaine and Polydrug Abuse: New Medication Strategies

$1,231,551
Mc Lean Hospital (Belmont, Ma) · P01 · FY2005 · DA

North Carolina Translational & Clinical Sciences Institute (NC TraCS)

$1,230,819
Marschall S. Runge · Univ Of North Carolina Chapel Hill · KL2 · FY2013 · TR

Protein Structure, Stability, and Amyloid Formation

$1,230,084
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Novel Antiangiogenic Peptides for Treatment of Exudative AMD

$1,230,010
Nader Sheibani · University Of Wisconsin-Madison · R24 · FY2014 · EY

Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis

$1,229,878
William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2017 · HL

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,229,753
Kevin Kit Parker · Harvard Medical School · U01 · FY2015 · HL

THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)

$1,229,306
Robert J Gropler · Washington University · P41 · FY2021 · EB

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,229,040
Kevin Kit Parker · Massachusetts General Hospital · U01 · FY2013 · HL

Preclinical Development of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip Fracture

$1,229,027
Harshini Neelakantan · Ridgeline Therapeutics, Llc · U44 · FY2021 · AG

Next generation drugs for bipolar depression and maintenance

$1,229,010
Thomas H Large · Blue Oak Pharmaceuticals, Inc. · R44 · FY2022 · MH

Ultra-high-throughput plate reader for drug discovery using all-optical electrophysiology

$1,228,439
Yang Lu · Quiver Bioscience Inc. · R44 · FY2022 · NS

The cBioPortal for Cancer Genomics

$1,228,423
Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2019 · CA